Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Aug 16, 2011 goldberg murray a Officer Automatic Sell 6,409 56.46 - 57.26
Jan 27, 2010 roberts william Officer Option Execute 6,500 13.00
Sep 7, 2011 roberts william Officer Automatic Sell 6,503 67.48 - 70.38
Dec 20, 2012 powchik peter Officer Automatic Sell 6,623 170.44 - 171.11
Aug 12, 2009 roberts william Officer Automatic Sell 6,666 22.99
Aug 12, 2009 roberts william Officer Option Execute 6,666 8.50
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Aug 24, 2012 mccorkle douglas s Officer Automatic Sell 6,727 142.71 - 146.07
Jun 3, 2010 kolinski stuart Officer Automatic Sell 6,784 30.02
Aug 7, 2014 van plew daniel p Officer Sell 6,806 338.37
Dec 16, 2014 mccorkle douglas s Officer Option Execute 6,818 30.63 - 52.03
Oct 4, 2010 goldstein joseph l Director Automatic Sell 6,848 27.45
Mar 9, 2011 brown michael s Director Automatic Sell 6,906 39.35 - 40.00
Feb 2, 2010 kolinski stuart Officer Automatic Sell 6,913 27.16
May 13, 2013 aberman michael s Officer Automatic Sell 6,971 275.97
Nov 14, 2012 brown michael s Director Sell 7,000 147.03
Nov 14, 2012 brown michael s Director Option Execute 7,000 23.84
May 10, 2012 ryan arthur f Director Disposition (Non Open Market) 7,000 n/a
Sep 6, 2011 schleifer leonard s Officer Automatic Buy 7,000 n/a
Feb 12, 2014 shooter eric m Director Acquisition (Non Open Market) 7,000 n/a
Showing 361-380 of 933 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)